Ozempic’s new frontier: The war on aging
Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.
Shocking stories of people who went blind after taking Ozempic and Mounjaro
Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...
Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher
The CEO of Novo Nordisk warned of the impact of tariffs on the pharmaceutical industry. Weight-loss drugs, including Ozempic ...
The rise of the Ozempic menu and how weight-loss drugs are changing dining out
With more diners skipping mains, drinking less and sharing starters because of weight-loss drugs, the traditional ...
Novo Nordisk shares fall on weight-loss drug trial
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.
Knowridge Science Report1d
Study finds new way to prevent obesity and diabetes
Anyone who has tried to lose weight by cutting calories knows the frustration—after initial success, weight loss slows down ...
The Pharma Letter3d
Russian generics producers start paying compensations to Novo Nordisk
Leading Russian drugmakers PSK Pharma and Promomed, which produce the analogues of Ozempic - a drug for the treatment of ...
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Ignore the noise in GLP-1 stocks. Find the best value instead.